Stay updated with breaking news from Nasdaq vrca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […] ....
Kornitzer Capital Management Inc. KS trimmed its position in shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) by 25.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,251 shares of the company’s stock after selling 25,000 shares during the period. […] ....
Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) dropped 3.5% during trading on Wednesday . The company traded as low as $5.10 and last traded at $5.17. Approximately 122,863 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 195,945 shares. The stock had previously closed at […] ....
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) major shareholder Perceptive Advisors Llc bought 500,000 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was purchased at an average cost of $5.97 per share, for a total transaction of $2,985,000.00. Following the completion of the acquisition, the insider now owns […] ....
Jefferies Financial Group reaffirmed their buy rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report issued on Friday morning, Benzinga reports. Jefferies Financial Group currently has a $10.00 price objective on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reduced their […] ....